ConferenceJournal of Clinical Oncology · October 20, 2018
Featured Publication
20 Background: More than 20% of US clinical trials fail to accrue sufficient patients and terminate prematurely, impeding innovation and negating the valuable contributions of participating patients. The aim of this study is to e ...
Full textCite